Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Joel R Eisner

3PUBLICATIONS

21CO-AUTHORS

Cancer geneticsPredictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 26, 2024

Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.

Joel R Eisner, Florus C de Jong, Yoichiro Shibata

|May 26, 2023

Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study.

Joel R Eisner, Gregory M Mayhew, James M Davison

|Mar 16, 2023

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer.

Joel R Eisner, Kirk D Beebe, Gregory M Mayhew

Pageof 1

Frequent Collaborators

3 joint publications

Kirk D Beebe

2 joint publications

Yuelong Guo

2 joint publications

Carol Farhangfar

2 joint publications

Gregory M Mayhew

2 joint publications

James M Davison

2 joint publications

Yoichiro Shibata

2 joint publications

Michael V Milburn

1 joint publications

David Foureau

1 joint publications

Farhang Farhangfar

1 joint publications

Joshua M Uronis

Frequent Collaborators

3 joint publications

Kirk D Beebe

2 joint publications

Yuelong Guo

2 joint publications

Carol Farhangfar

2 joint publications

Gregory M Mayhew

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

See more related videos